September 21, 2012
Mitsubishi Tanabe Pharma Corporation (MTPC) announced on September 20 that its subsidiary P.T. Tanabe Indonesia started on September 3 marketing the humanized anti-human TNFα monoclonal antibody Simponi Subcutaneous Injection 50 mg (recombinant golimumab) for the treatment of rheumatoid arthritis (RA),...read more